
Selection and early clinical evaluation of the brain-penetrant 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitor UE2343 (Xanamem™)
Webster, Scott P, McBride, Andrew, Binnie, Margaret, Sooy, Karen, Seckl, Jonathan R, Andrew, Ruth, Pallin, T David, Hunt, Hazel J, Perrior, Trevor R, Ruffles, Vincent S, Ketelbey, J William, Boyd, AlaVolume:
174
Langue:
english
Journal:
British Journal of Pharmacology
DOI:
10.1111/bph.13699
Date:
March, 2017
Fichier:
PDF, 632 KB
english, 2017